Stryker SYK
NYSE SYK
$332.08 -7.90 (-2.33%)
At close: Aug 20, 2026 · 2:37 PM UTC

Stryker (SYK) Cash from Investing Activities (2009 - 2026)

Stryker (SYK) posted quarterly Cash from Investing Activities of -$639.0 million for Q2 2026, down 514.42% year-over-year from $154.2 million in Q2 2025, and down 245.41% on a QoQ basis from -$185.0 million in Q1 2026.

Stryker (SYK) Cash from Investing Activities (2009 - 2026) Analysis & Trends

Stryker has reported Cash from Investing Activities for 18 years, with the latest figure at -$639.0 million in Q2 2026.

  • Cash from Investing Activities for Q2 2026 came in at -$639.0 million, down 514.42% year-over-year; the trailing twelve-month figure through Jun 2026 was -$1.5 billion (up 78.41% YoY), and the FY2025 annual result was -$4.9 billion, down 62.2% from the prior year.
  • Cash from Investing Activities slipped to -$639.0 million in Q2 2026, from -$185.0 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $72.0 million in Q3 2022 and troughed at -$4.1 billion in Q1 2025.
  • A 5-year average of -$698.7 million and a median of -$244.0 million in 2024 frame the typical range for Cash from Investing Activities.
  • The largest YoY upside for Cash from Investing Activities was 129.15% in 2022 against a maximum downside of 2693.75% in 2022.
  • A 5-year view of Cash from Investing Activities shows it stood at -$162.0 million in 2022, then grew by 6.17% to -$152.0 million in 2023, then slumped by 99.34% to -$303.0 million in 2024, then slipped by 0.66% to -$305.0 million in 2025, then sank by 109.51% to -$639.0 million in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were -$639.0 million in Q2 2026, -$185.0 million in Q1 2026, and -$305.0 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 199.63 Bn 194.02 Bn 7.27 Bn -673.00 Mn
2 Stryker 127.42 Bn 123.95 Bn 4.50 Bn -639.00 Mn
3 Medtronic 118.97 Bn 109.75 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 73.39 Bn 72.85 Bn 3.85 Bn -1.96 Bn
5 Edwards Lifesciences 51.97 Bn 47.72 Bn 1.35 Bn -193.20 Mn
6 Dexcom 34.32 Bn 32.37 Bn 830.00 Mn 329.80 Mn
7 GE HealthCare Technologies 33.76 Bn 31.65 Bn 2.18 Bn -115.00 Mn
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn -22.08 Mn
9 Steris 23.04 Bn 22.56 Bn 684.20 Mn -108.50 Mn
10 Zimmer Biomet Holdings 19.18 Bn 18.77 Bn 1.54 Bn -190.80 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -639.00 Mn
Jun 30, 2026 -639.00 Mn
Mar 31, 2026 -185.00 Mn
Mar 31, 2026 -185.00 Mn
Dec 31, 2025 -305.00 Mn
Dec 31, 2025 -305.00 Mn
Sep 30, 2025 -321.00 Mn
Sep 30, 2025 -321.00 Mn
Jun 30, 2025 -104.00 Mn
Jun 30, 2025 -104.00 Mn
Mar 31, 2025 -4.14 Bn
Mar 31, 2025 -4.14 Bn
Dec 31, 2024 -303.00 Mn
Dec 31, 2024 -303.00 Mn
Sep 30, 2024 -2.17 Bn
Sep 30, 2024 -2.17 Bn
Jun 30, 2024 -117.00 Mn
Jun 30, 2024 -117.00 Mn
Mar 31, 2024 -408.00 Mn
Mar 31, 2024 -408.00 Mn